Tom Gumley
FPA Patent Attorneys
Articles
What impact will the Australian Myriad decision have on patent eligibility of diagnostic tests?
Australia - October 23 2015 By now most will know that: Australia’s final appeal Court has made adverse findings against Myriad’s patent for utilising the BRCA1 locus to…
What did the Australian High Court actually say about the patent eligibility of cDNA?
Australia - October 19 2015 As the dust from the impact of the Australian Myriad decision begins to settle, now is the time to revisit what many have said regarding patent…
“Does a nucleic acid constitute patent eligible subject matter under Australia law?”
Australia - October 19 2015 That is the question that we hoped Australia’s final appeal Court to have answered in the Myriad decision that it handed down last week. Some…
High Court of Australia determines isolated BRCA1 gene not patentable in Australia
Australia - October 7 2015 The High Court of Australia has unanimously overturned previous decisions from lower courts and has held that certain claims to Myriad's patent for…
European alliance of plant breeders fails to halt the march of the Nagoya Protocol
Australia, European Union - July 7 2015 The CJEU has rejected two challenges to the EU Regulation implementing the Nagoya Protocol. This piece of international law has changed significantly…
